Morphological Characteristics of Abdominal Adipose Tissue in Normal-Weight and Obese Women of Different Metabolic Profiles

Abstract

Background and Aims: Morphological changes in adipose tissue reflect functional disorders that correlate with cardiometabolic complications of obesity. The metabolic risks vary among the obese individuals. Furthermore, normal-weight individuals are not necessarily metabolically healthy. Therefore, the aim of this study was to analyze morphological characteristics of the abdominal adipose tissue in normal-weight and obese individuals in regards to metabolic risks.

Methods and Results: The study group consisted of 30 overweight or obese and 20 normal-weight women undergoing elective surgery. Women of each group were divided into metabolically healthy and metabolically obese, based on the homeostasis model assessment of insulin resistance (HOMA-IR), triglyceride, total-, LDL- and HDL-cholesterol levels. The size and numerical density of adipocytes, as well as volume density of blood vessels in subcutaneous and visceral adipose tissue were compared among subgroups. The results showed hypertrophy of adipocytes of visceral adipose tissue in metabolically obese normal-weight women. At the same time, metabolically healthy obese women had smaller adipocytes in both depots in comparison with “at risk” obese women. The lowest volume density of blood vessels correlated with the largest diameter of adipocytes in “at risk” obese women indicating hypoxic changes in visceral adipose tissue. The observed differences of the adipose tissue morphology did not correlate with considerable phenotypic differences within either the normal-weight or obese women group.

Conclusion: Changes in adipocyte size, cellular and vascular density of adipose tissue in relation with metabolic disorders, regardless of nutritional level, suggest limited capacity of fat deposition and adipose tissue response to hypoxia.

Key words

obesity - cardiovascular risk management - cardiovascular incidences - metabolic features

References

• 1 Brochu M, Tchernof A, Dionne IJ. et al . What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?.  J Clin Endocrinol Metab. 2001;  86 1020-1025
• 2 Cinti S, Mitchell G, Barbatelli G. et al . Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans.  J Lip Res. 2005;  46 2347-2355
• 3 Cinti S. The adipose organ.  Prostag Leukotr Ess. 2005;  73 9-15
• 4 Coppack SW. Adipose tissue changes in obesity.  Biochem Soc Trans. 2005;  33 (5) 1049-1052
• 5 Friedewald WT, Levy RI, Frericjkson DS. Estimation of the concetracion of low-density lipoprotein cholesterol in plasma, without use of the preparative centrifuge.  Clin Chem. 1972;  18 (6) 499-502
• 6 Gokalp D, Bahceci M, Ozmen S. et al . Adipocyte volumes and levels of adipokines in diabetes and obesity.  Diab Met Syndr Clin Res Rev. 2008;  DOI: doi: 10.1016/j.dsx.2008.07.001
• 7 Goossens GH. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance.  Physiol Behav. 2008;  94 206-218
• 8 Karelis AD, Brochu M, Rabasa-Lhoret R. et al . Clinical markers for the identification of metabolically healthy but obese individuals.  Diab Obes Metab. 2004a;  6 456-457
• 10 Karelis AD, St-Pierre DH, Conis F. et al . Metabolic and body composition factors in subgroups of obesity: what do we know?.  J Clin Endocrinol Metab. 2004b;  89 (6) 2569-2575
• 9 Karelis AD, Brochu M, Rabasa-Lhoret R. Can we identify metabolically healthy but obese individuals (MHO)?.  Diabetes & Metabolism. 2005;  30 (6) 569-572
• 11 Karpe F, Tan GD. Adipose tissue function in the insulin-resistance syndrome.  Biochem Soc Trans. 2005;  33 (5) 1045-1048
• 12 Lafontan M, Girard J. Impact of visceral adipose tissue on liver metabolism. Part I: Heterogenity of adipose tissue and functional properties of visceral adipose tissue.  Diabetes Metab. 2008;  DOI: doi: 10.1016/j.diabet.2008.04.001
• 13 Matthews DR, Hosker JP, Rudenski AS. et al . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.  Diabetologia. 1985;  28 412-419
• 14 Monteiro R, de Castro PMST, Calhau C. et al . Adipocyte size and liability to cell death.  Obes Surg. 2006;  16 804-806
• 15 Müller MJ, Hebebrand J. Should We Really Treat Every Obese Individual?.  Obesity Facts. 2008;  1 287-291
• 16 Rajala MW, Scherer PE. The adipocyte – at the crossroads of energy homeostasis, inflammation, and atherosclerosis.  Endocrinology. 2003;  144 (9) 3765-3773
• 17 Roche AF. The adipocyte-number hypothesis.  Child Dev. 1981;  52 31-43
• 18 Ruderman NB, Schneider SH, Berchtold P. The “metabolically-obese”, normal-weight individual.  Am J Clin Nutr. 1981;  34 1617-1621
• 19 Shin MJ, Hyun YJ, Kim OY. et al . Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women.  Int J Obes. 2005;  30 (10) 1529-1534
• 20 Slawik M, Vidal-Puig AJ. Adipose tissue expandibility and the metabolic syndrome.  Genes Nutr. 2007;  2 41-45
• 21 Smith J, Al-Amri M, Dorairaj P. et al . The adipocyte life cycle hypothesis.  Clin Sci. 2006;  110 1-9
• 22 Stefan N, Kantartzis K, Machann J. et al . Identification and Characterization of Metabolically Benign Obesity in Humans.  Arch Intern Med. 2008;  168 (15) 1609-1616
• 23 Tan CY, Vidal-Puig A. Adipose tissue expandability : the metabolic problems of obesity may arise from the inability to become more obese.  Biochem Soc Trans. 2008;  36 935-940
• 24 Thompson SW, Hunt RD. Selected histochemical and histopathological methods.. 2nd ed. Charles C. Thomas, Springfield, IL 1966
• 25 Trayhurn P, Wood I. Adipokines: inflammation ant the pleiotropic role of white adipose tissue.  Br J Nutr. 2004;  92 347-355
• 26 Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome.  Endocr Rev. 2000;  21 (6) 697-738
• 27 Weibel ER, Elias H. Introduction to stereological principles.. Berlin-Heidelberg-New York: Springer Verlag; 1967: 89-97
• 28 Wildman RP, Muntner P, Reynolds K. et al . The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering – prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004).  Arch Int Med. 2008;  168 (15) 1617-1624
• 29 World Health Organization . Obesity: preventing and managing the global epidemic. Report of a WHO consultation.  World Health Organ Tech Rep Ser. 2000;  894 1-253
• 30 You T, Ryan AS, Nicklas BJ. The metabolic syndrome in obese postmenopausal women: relationship to body composition, visceral fat, and inflammation.  J Clin Endocrinol Metabol. 2004;  89 (11) 5517-5522

Correspondence